NuCana grabs $57 mln Series B funds

NuCana has raised $57 million in Series B funding. Sofinnova Ventures led the round with participation from Sofinnova Partners, Morningside Ventures, Alida Capital International and the Scottish Investment Bank, the investment arm of Scottish Enterprise. In addition to the funding, James Healy and Gerald Chan, co-founder and chairman of Morningside Ventures respectively, have been added to NuCana’s board of directors. Based in Edinburgh, NuCana is an biopharmaceutical firm focused on anti-cancer medicines.

125 Views

VC-backed Versartis raises $126 mln for IPO

Versartis has launched its IPO after pricing its 6 million shares at $21 per share. The stock began trading Friday on the NASDAQ under the ticker symbol “VSAR.” Morgan Stanley and Citigroup are the lead underwriters. Based in Redwood City, Calif., Versartis is an endocrine-focused biopharmaceutical company focused on treating growth hormone deficiency. Its backers include Sofinnova Ventures, Aisling Capital, New Leaf Venture Partners and Advent Life Sciences.

First Aid Shot Therapy completes Series B

Consumer healthcare company First Aid Shot Therapy has completed a Series B financing round. Sofinnova Ventures and Redmile Group co-led the round with additional support from investors including Sofinnova HealthQuest, Clearwell Group and Mark Rampolla, founder and former CEO of ZICO Beverages, maker of ZICO Pure Premium Coconut Water.

Crocus Technology Secures $45m Series D

Crocus Technology, a developer of magnetically enhanced semiconductor technologies for mobile security, embedded microcontrollers, harsh environment electronics and magnetic sensors, has raised 34 million euros ($45 million) in additional capital. A new private investor, Industrial Investors, joined the round led by Idinvest Partners. Major investors Sofinnova Ventures, Innovation Capital, Nanodimension and Ventech also participated.

Guavus Acquires Neuralitic Systems

Guavus, a provider of big data analytics solutions, has acquired Neuralitic Systems, a mobile data monetization and marketing analytics experts serving the telecommunications industry. Guavus is backed by Investor Growth Capital, QuestMark Partners and previous investors Artiman Ventures, Sofinnova Ventures and Intel Capital.

Guavus Raises $30m Funding

Guavus, a provider of big data analytics solutions has closed a $30 million round of new funding. Investor Growth Capital led the round with participation from QuestMark Partners and previous investors Artiman Ventures, Sofinnova Ventures and Intel Capital.

Salveo Completes Additional Financings and Acquisition

Specialty pharmacy company Salveo Specialty Pharmacy has completed a second round of equity and debt funding and the subsequent acquisition of Mission Road Pharmacy. Salveo Specialty Pharmacy is backed by Three Arch Partners, NewSpring Capital and Petra Capital Partners. The additional equity financing was led by new investor Sofinnova Ventures. The debt financing included additional subordinated debt provided by Petra, as well as a new senior credit facility provided by Regions Bank.

Phizer Buys VC-Backed NextWave Pharmaceuticals

Phizer is snapping up NextWave Pharmaceuticals—a company backed by a laundry list of investors including Panorama Capital, Bay City Capital, Kearny Venture Partners, Aisling Capital, Fidelity Biosciences, Sofinnova Ventures and Vivo Ventures. Under the terms of the deal, Pfizer will pay $255 million to NextWave’s shareholders at closing. NextWave’s shareholders are eligible to receive up to $425 million in additional money, based on sales milestones. NextWave closed a $45 million round last January.

PEHUB Community

Join the 12493 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

Look Who’s Tweeting

Reuters VC and PE feed

RSS Feed Widget

Groups